Issued Patents All Time
Showing 1–25 of 31 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 6576431 | Antibodies that bind to &agr;2-antiplasmin crosslinked to fibrin which do not inhibit plasma &agr;2-antiplasmin | Guy L. Reed, Gary R. Matsueda | 2003-06-10 |
| 6280730 | Antibodies that bind to .alpha.2-antiplasmin crosslinked to fibrin which do not inhibit plasma .alpha.2-antiplasmin | Guy L. Reed, Gary R. Matsueda | 2001-08-28 |
| 6258557 | Smooth muscle cell LIM promoter | Mu-En Lee, Mukesh Jain, Shaw-Fang Yet | 2001-07-10 |
| 6248933 | Cellular basis of vascular-graft stenosis | Chengwei Shi, Nicholas E. S. Sibinga | 2001-06-19 |
| 6136953 | Smooth muscle cell LIM protein | Mu-En Lee, Mukesh Jain, Shaw-Fang Yet | 2000-10-24 |
| 5888765 | Endothelial-cell specific promoter | Winston Campbell Patterson, Mu-En Lee | 1999-03-30 |
| 5831031 | Antibodies that bind to .alpha.2-antiplasmin crosslinked to fibrin which do not inhibit plasma .alpha.2-antiplasmin | Guy L. Reed, Gary R. Matsueda | 1998-11-03 |
| 5811265 | Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use | Thomas Quertermous, Marschall S. Runge | 1998-09-22 |
| 5767262 | Smooth muscle cell LIM protein | Mu-En Lee, Mukesh Jain, Shaw-Fang Yet | 1998-06-16 |
| 5675062 | Cellular basis of transplant arteriosclerosis in mice | Chengwei Shi, Wen-Sen Lee | 1997-10-07 |
| 5620688 | Methods of inhibiting the activation of Factor XIII | Guy L. Reed, Gary R. Matsueda | 1997-04-15 |
| 5609869 | Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use | Thomas Quertermous, Marschall S. Runge | 1997-03-11 |
| 5582862 | Antibodies that bind to .alpha.2-antiplasmin crosslinked to fibrin which do not inhibit plasma .alpha.2-antiplasmin | Guy L. Reed, Gary R. Matsueda | 1996-12-10 |
| 5571523 | Antioxidant-induced apoptosis in vascular smooth muscle cells | Mu-En Lee, Jer-Chia Tsai | 1996-11-05 |
| 5453269 | Heterobifunctional antibodies having dual specificity for fibrin and thrombolylic agents and methods of use | Christoph Bode | 1995-09-26 |
| 5443827 | Fibrin-targeted inhibitors of thrombin | Christoph Bode, Marschall S. Runge | 1995-08-22 |
| 5372812 | Composition and method for acceleration of clot lysis | Guy L. Reed, Gary R. Matsueda | 1994-12-13 |
| 5357042 | Synthetic peptides capable of eliciting fibrin-specific monoclonal antibodies lacking fibrinogen-cross-reactivity | Gary R. Matsueda, Kwan Hui | 1994-10-18 |
| 5256413 | Method and use for site-specific activation of substances | Gary R. Matsueda | 1993-10-26 |
| 5223241 | Method for early detection of allograft rejection | Mitsuaki Isobe, Ban-An Khaw | 1993-06-29 |
| 5116613 | Antibody-thrombolytic agent product and method of use | Gary R. Matsueda | 1992-05-26 |
| 4927916 | Method of producing fibrin-specific monoclonal antibodies lacking fibrinogen-cross-reactivity using fibrin-specific peptides | Gary R. Matsueda, Kwan Hui | 1990-05-22 |
| 4916070 | Fibrin-specific antibodies and method of screening for the antibodies | Gary R. Matsueda | 1990-04-10 |
| 4803167 | Monoclonal antidigoxtin antibodies | Meredith Mudgett-Hunter, Michael N. Margolies | 1989-02-07 |
| 4661224 | Process and apparatus for electrically desorbing components selectively sorbed on an electrolytically conducting barrier | Arthur L. Goldstein, Robert J. Mandle | 1987-04-28 |